A detailed history of Moody National Bank Trust Division transactions in United Therapeutics Corp stock. As of the latest transaction made, Moody National Bank Trust Division holds 3,588 shares of UTHR stock, worth $1.29 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
3,588
Previous 3,491 2.78%
Holding current value
$1.29 Million
Previous $1.11 Million 15.56%
% of portfolio
0.14%
Previous 0.09%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

BUY
$311.04 - $363.55 $30,170 - $35,264
97 Added 2.78%
3,588 $1.29 Million
Q2 2024

Jul 03, 2024

BUY
$228.26 - $319.04 $6,847 - $9,571
30 Added 0.87%
3,491 $1.11 Million
Q1 2024

Apr 04, 2024

BUY
$210.76 - $249.51 $8,219 - $9,730
39 Added 1.14%
3,461 $795,000
Q4 2023

Jan 11, 2024

BUY
$214.88 - $256.94 $735,319 - $879,248
3,422 New
3,422 $752,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Moody National Bank Trust Division Portfolio

Follow Moody National Bank Trust Division and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moody National Bank Trust Division, based on Form 13F filings with the SEC.

News

Stay updated on Moody National Bank Trust Division with notifications on news.